Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01524276 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Product Surveillance Registry

Study acronym: PSR
StatusRecruiting
PhaseNot specified
SponsorMedtronic
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 75 record versions are listed below. See every version on ClinicalTrials.gov ↗

  1. Study sites: 400 to 401
  2. Re-verified, no change to tracked fieldsv74
  3. Trial sites expanded: 395 → 400 locationsv73
  4. Study sites: 393 to 395v72
  5. Study sites: 391 to 393v71
Show 45 earlier versionsHide 45 earlier versions
  1. Study sites: 389 to 391v70
  2. Study sites revised (389)v69
  3. Study sites: 388 to 389v68
  4. Study sites: 389 to 388v67
  5. Study sites: 388 to 389v66
  6. Study sites: 385 to 388v65
  7. Study sites: 382 to 385v64
  8. Study sites: 381 to 382v63
  9. Study sites: 380 to 381v62
  10. Study sites: 381 to 380v61
  11. Study sites: 366 to 381v60
  12. Study sites: 364 to 366v59
  13. Study sites: 365 to 364v58
  14. Study sites: 364 to 365v57
  15. Primary and study completion dates: Jan 2030 to Jan 2040
    • Study sites: 366 to 364
    v56
  16. Study sites: 365 to 366v55
  17. Study sites: 362 to 365v54
  18. Study sites: 361 to 362v53
  19. Study sites revised (361)v52
  20. Study sites: 360 to 361v51
  21. Study sites: 361 to 360v50
  22. Study sites: 351 to 361v49
  23. Study sites: 350 to 351v48
  24. Study sites: 338 to 350v47
  25. Study sites: 325 to 338v46
  26. Study sites: 380 to 325v45
  27. Study sites: 402 to 380v44
  28. Study sites revised (402)v43
  29. Study sites revised (402)v42
  30. Study sites: 399 to 402v41
  31. Study sites: 397 to 399v40
  32. Study sites: 392 to 397v39
  33. Re-verified, no change to tracked fieldsv38
  34. Study sites: 386 to 392v37
  35. Study sites: 392 to 386v36
  36. Study sites: 380 to 392v35
  37. Study sites revised (380)v34
  38. Study sites: 378 to 380v33
  39. Study sites: 379 to 378v32
  40. Study sites: 375 to 379v31
  41. Study sites: 372 to 375v30
  42. Study sites: 367 to 372v29
  43. Study sites: 366 to 367v28
  44. Study sites: 362 to 366v27
  45. Study sites: 361 to 362v26
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by streamlining the clinical surveillance process and facilitating leading edge performance assessment via the least burdensome approach.
Trial Details
NCT Number NCT01524276
Lead Sponsor Medtronic
Conditions
(from sponsor)		 Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders, Digestive Disorders, Intracranial Aneurysm, Mechanical Circulatory Support, Respiratory Therapy +8 more
Related terms Cardiovascular Diseases, Coronary Artery Disease, Digestive System Diseases, Intracranial Aneurysm, Nervous System Diseases, Renal Insufficiency, Urologic Diseases
Enrollment 100,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov